Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
Is there a role for bevacizimab (IV or IA) for steroid refractory radionecrosis for AVM?
Related Questions
What are your top takeaways in Neuro Oncology from ASTRO 2024?
Would you prefer SBRT or fractionated radiation for a sacral peripheral nerve sheath tumor?
What is your approach to management of a subtotally resected pineal parenchymal tumor of intermediate differentiation (CNS WHO grade 2)?
How would you approach treatment for a glioblastoma from a radiation standpoint that was initially thought to be a metastases and therefore treated with multiple courses of SRS over the past few years?
Do you ever consider a third course of CNS radiation to the same area for an in-field recurrence?
Under what circumstances would you consider irradiation for brain metastases with active or recent bleeding?
Would you offer hypofractionation for a larger AVM?
How would you treat grade 3 cauda equina meningioma status post biopsy only with a history of prior prostate/whole pelvis radiation?
Do you prescribe prophylactic steroids to patients receiving radiosurgery for AVMs?
What is the role of radiation in intra labyrinthine (cochlear) schwannoma?